ArticleJournal of medical biochemistry2026
Prognostic value of inflammatory biochemical markers (IL-8, PCT, CRP) for cardiovascular disease in patients with pancreatitis.
Article in Journal of medical biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with pancreatitis may be at increased risk of cardiovascular disease (CVD), but the biochemical mechanisms underlying this risk are not fully defined. Inflammatory biomarkers may provide valuable prognostic information. Methods: We retrospectively analyzed 180 patients with pancreatitis (Jan 2021-Dec 2023). Serum levels of interleukin-8 (IL-8), procalcitonin (PCT), tumor necrosis factor-a (TNF-a), and C-reactive protein (CRP) were quantified using enzyme-linked immunosorbent assay (ELISA) and routine laboratory tests. Logistic regression was applied to identify independent biochemical predictors of CVD, and a risk prediction model was developed and validated using ROC curve analysis. Results: IL-8, PCT, CRP and age emerged as independent predictors of CVD occurrence in pancreatitis patients (all P< 0.05). The biochemical prediction model demonstrated high accuracy, with an AUC of 0.893 in the training set and 0.978 in the validation set. Sensitivity and specificity exceeded 85% across datasets. Conclusions: This study highlights the clinical and laboratory significance of inflammatory biomarkers in pancreatitis. The proposed biochemical model provides a reliable tool for predicting cardiovascular risk and may contribute to improved laboratory-guided risk assessment and patient management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.